Business Blockbuster - Helpng business to be more visible on Google

Business Daily Media


.

A Defining Milestone for Gene Solutions: SPOT-MAS Multi-Cancer Screening Test Receives U.S. FDA Breakthrough Device Designation

HONG KONG SAR - Media OutReach Newswire - 22 July 2026 - Gene Solutions – a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, announced that SPOT-MAS 10 has received Breakthrough Device Designation from the U.S.

Food and Drug Administration (FDA). This designation marks an important regulatory milestone for Gene Solutions and reflects the continued progress of SPOT-MAS as an AI-powered, multi-omic platform for early cancer detection.

SPOT-MAS Multi-Cancer Screening Test Receives U.S. FDA Breakthrough Device Designation
SPOT-MAS Multi-Cancer Screening Test Receives U.S. FDA Breakthrough Device Designation

The proposed indications for use describe SPOT-MAS 10 as a qualitative in vitro diagnostic test performed on plasma derived from a single direct-draw venous whole blood specimen. The test analyzes circulating cell-free DNA methylation and fragmentomic signatures using a machine-learning-based algorithm to detect a cancer-associated signal. It is intended for use as an adjunctive screening test in asymptomatic adults aged 40 years and older to assist in detecting cancers within the scope of the assay. These include five common cancers — breast, lung, liver, colorectal and gastric cancers — and five aggressive, less common cancers that currently lack standard screening methods — ovarian, pancreatic, esophageal, endometrial and head & neck cancers.

SPOT-MAS has been developed through years of rigorous scientific research and clinical development. In March 2025, SPOT-MAS became the first multi-cancer screening blood test in Asia to complete a large prospective cohort validation, with the K-DETEK study evaluating more than 9,000 asymptomatic participants and demonstrating strong performance, including high specificity and the ability to identify cancer-associated signals across multiple cancer types.

Since then, SPOT-MAS has been used in more than 100,000 individuals in real-world practice, with consistent performance observed beyond controlled study settings. Real-world data were presented at ESMO Asia 2025 and were featured at ASCO Breakthrough 2026 in Singapore.

The platform is built on a multi-omic approach— integrating genetics, epigenetics, and fragmentomics — together with AI-driven analysis, large-scale prospective validation, growing real-world evidence and focus on cancer types with high clinical relevance in the regions where the test is deployed.

For the United States, Breakthrough Device Designation provides Gene Solutions with a prioritized channel of engagement with the FDA as the company advances its U.S. development and validation plans.

Looking ahead, Gene Solutions will continue to collaborate with academic, clinical, laboratory, commercial and strategic partners to support responsible adoption of SPOT-MAS in accordance with local regulations, clinical guidelines and best practices.

Important Regulatory Notice: SPOT-MAS 10 has received U.S. FDA Breakthrough Device Designation. Breakthrough Device Designation is not FDA approval, clearance or marketing authorization. The device remains subject to applicable FDA regulatory review requirements, and the designation does not guarantee future FDA approval, clearance or authorization.

For more information, visit https://spotmas.com.hk

Contact:
hk.cs@genesolutions.com
Source: Gene Solutions Hong Kong Limited.
SPOTMAS_062026_04



Hashtag: #SPOTMAS


The issuer is solely responsible for the content of this announcement.

News from Asia

Puffin Secure Browser is back with a security-first focus built on its proven cloud architecture

After more than a decade developing cloud-based browser technology, CloudMosa is reintroducing Puffin Secure Browser with a security-first architecture at its core to help address AI-driven cyberat...

Singapore’s iCOMPASS Launches KY-AI to Help Financial Institutions Govern Autonomous AI Under New MAS Guidelines

Singapore-developed platform brings AI inventory, risk assessment, approvals, testing and ongoing oversight into a structured governance process.SINGAPORE - Media OutReach Newswire - 18 November 2...

The Longines Hong Kong International Horse Show and The Hong Kong Jockey Club Champion the Next Generation Through the Asia Pacific Youth Challenge

Asia Pacific’s rising star riders set their sights on the January 2027 Show, alongside family-focused ways for young fans to experience equestrian sport. Tickets are now available via HK Ticketin...

Singapore Becomes Launchpad for Lean Deep-Tech Teams Going Global Within Months, Osome Data Shows

SINGAPORE - Media OutReach Newswire - 18 November 2026 - As the Singapore FinTech Festival (SFF) returns from 18 to 20 November to examine how finance is being rewired, Osome, the AI company manag...

New WEIKEN Showroom at Paya Lebar Opens Its Doors with an Exclusive Homeowners Launch Event

SINGAPORE – Media OutReach Newswire – 18 November 2026 – Weiken @ AZ Paya Lebar, the brand's newest showroom at 140 Paya Lebar Road, officially opened on 13 November 2026, giving Singapore homeow...

Jackson Wang’s Wax Figure Arrives at Madame Tussauds Singapore for a Limited-Time Experience

Step into Hallyu: Enter Your Bias's World. No Screen. No Barrier.SINGAPORE - Media OutReach Newswire - 18 November 2026 - Get ready to step into the world of Hallyu! Madame Tussauds Singapore invi...

China’s Recombinant Collagen Technology Wins the INPD Innovative Manufacturing Process Award

PARIS, FRANCE – Media OutReach Newswire – 18 November 2026 – From 14 to 15 October 2026, the 2026 INPD Award was held at the Carrousel du Louvre in Paris, France...

Allocator One Launches with $100M+ Venture Capital Fund of Funds, with 17 Unicorns in Portfolio

Allocator One emerges from stealth; Flagship Fund I's underlying fund investments report 11% DPI; the firm expands across Asia-Pacific from its Singapore hub and hosts Alpha Summit Asia on 18 Novem...

Arrow Electronics to showcase technologies and engineering capabilities for intelligent edge AI systems at EdgeTech+

YOKOHAMA, JAPAN – Media OutReach Newswire – 18 November 2026 – Arrow Electronics, a global provider of technology solutions, is showcasing technologies and engineering capabilities for intelligen...

TCMA Advances ASEAN Cement Decarbonization with 14.4 Mt. of CO₂ Reductions

Building Global Partnerships and Technology Connections towards the 27th AFCM Technical Symposium & Exhibition 2027BANGKOK, THAILAND – Media OutReach Newswire – 18 November 2026 – Thai Cement...

Why the secrecy around car insurance?

Every year, millions of Australians receive their car insurance renewal and promise themselves they’ll look at it properly later. Then life gets in ...

Australian workers spend almost an hour a day administering email

Research finds email filing, searching and rework consuming an estimated 58 minutes a day and potentially exposing organisations to millionsAustralian...

Customer Service Is Becoming Part of the Small Business Sales and Marketing Engine

For Customer Service Week, 5-9 October, Thryv is urging small businesses to look beyond generating  enquiries and examine what happens after a custome...

Gift Cards as the gateway to agentic payments

Prepaid and stored value gives consumers the trust and control to try AI shopping agents By Blackhawk Network VP Head of ANZ Kieran Nolan For deca...

Why Data Accumulation Without Governance Undermines Sustainability Goals

In July 2026, Group 2 entities, the second cohort of Australian businesses, began their first reporting period under the mandatory climate disclosur...

Permanent $20,000 Instant Asset Write-Off Gives Small Businesses Greater Planning Certainty

The Federal Government’s decision to permanently legislate the $20,000 instant asset write-off will give eligible small businesses greater certainty...